NR vs NMN in 2026: the NAD+ Precursor That Is Actually Studied and Sellable
What NAD+ actually does
NAD+ (nicotinamide adenine dinucleotide) sits at the center of cellular energy metabolism and DNA repair. Levels decline with age, which is why raising NAD+ became one of the central strategies in longevity research. You cannot supplement NAD+ directly to any useful effect — the molecule is too large to absorb well — so the market moved to precursors your body converts into NAD+.
The regulatory fork
Here is what most brand marketing skips: in late 2022 the FDA concluded NMN cannot be marketed as a dietary supplement in the US, because it was first studied as an investigational drug. Enforcement has been uneven, and NMN still appears on shelves — but its legal footing is unstable. NR took the opposite path: GRAS affirmation, an accepted new-dietary-ingredient filing, and multiple published human trials of the branded form. If a US company gives a sh*t about doing it properly, NR is the precursor that holds up.
The dose
Human studies of NR most commonly use 300mg per day, with doses up to 1,000mg tested for safety. 300mg is the standard consumer research dose — which is why ONCE carries exactly that, disclosed on the label rather than buried in a blend, alongside 750mg of TMG, the methyl-donor support the NAD+ community pairs with any precursor.
Get First Access to ONCEThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not medical advice; consult a physician before starting any supplement.